http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H03169818-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28a869d6fc950d50f6df03f549ca3afa |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-59 |
| filingDate | 1990-09-14^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31c3035ff753b748de55963e4dd5d55f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66302d62999ec4b3d49d38b668939712 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6984adb6502ef5f817f54e6a19e26d95 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9eeb59031cdf32a6ae484ecf74a5a7dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdf894e92d7c69294a3ee489d994c7b5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21227f83c00ebb0c280f3537d1bc3b8a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdcb1ffcb79bd57ed12352be1422b5d1 |
| publicationDate | 1991-07-23^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H03169818-A |
| titleOfInvention | Inhibitor of blood platelet agglutination containing 1alpha-hydroxyvitamin d3 compounds |
| abstract | PURPOSE: To obtain a inhibitor of blood platelet agglusination containing a 1α-hydroxyvitamin D 3 as an active ingredient. n CONSTITUTION: A 1α-hydroxyvitamin D 3 is contained as an active ingredient and pharmaceutically manufactured into an administration form such as compressed tablet, coated tablet, hard or soft elastic gelatin capsule, ethyl alcohol solution, oily or aqueous solution or suspension to give the objective substance. In the case of administration in the rectum, a drug composition containing suppository base such as cacao butter or triglyceride thereof may be prepared. Two or more kinds of 1α-hydroxyvitamin D 3 compds. are mixed and used, 2×10 -5 -1×10% of the substance is contained in a unit administration form and a dose is 0.1-10 4 μg/day/person and dividedly administered once to three times. n COPYRIGHT: (C)1991,JPO&Japio |
| priorityDate | 1983-08-02^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 28 of 28.